Literature DB >> 8062781

Use of anthropometric indicators and maternal risk factors to evaluate intrauterine growth retardation in infants weighing more than 2500 grams at birth.

H Balcazar1, L Keefer, T Chard.   

Abstract

The overall objectives of this study were to characterize the patterns of IUGR of infants weighing more than 2500 g at birth and to identify pregnancy-related risk factors associated with IUGR. A total of 195 term newborns were studied from a Pediatric Hospital in the city of Hermosillo, Sonora, Mexico. The experimental group consisted of 140 newborns whose birth weights ranged between 2500 and 3200 g. A total of 55 non-IUGR infants were included in the control group whose birth weights were between 3200 and 4000 g. IUGR was evaluated based on the fetal growth ratio method defined as the observed birth weight at a given gestational age to the mean birth weight using a sex-specific reference growth standard. Overall, 35% of infants weighing between 2500-3200 g showed patterns of IUGR. These patterns of underweight were associated with lower values in several of the anthropometric indicators and proportionality ratios used. Of all the maternal risk factors evaluated only previous history of low birth weight was found to be statistically significant between IUGR and non-IUGR groups, after adjustment of several control variables. Further analysis of IUGR infants with maternal history of low birth weight demonstrated significantly lower mean values for a variety of anthropometric indicators in comparison to non-IUGR infants without maternal history of low birth weight.

Entities:  

Mesh:

Year:  1994        PMID: 8062781     DOI: 10.1016/0378-3782(94)90001-9

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  8 in total

1.  Demographic models of birth outcomes and infant mortality: an alternative measurement approach.

Authors:  P Solís; S G Pullum; W P Frisbie
Journal:  Demography       Date:  2000-11

2.  Compromised birth outcomes and infant mortality among racial and ethnic groups.

Authors:  W P Frisbie; D Forbes; S G Pullum
Journal:  Demography       Date:  1996-11

3.  Comment on "Compromised birth outcomes and infant mortality among racial and ethnic groups".

Authors:  W J van der Veen
Journal:  Demography       Date:  1998-11

4.  Birth outcome, not pregnancy process: reply to van der Veen.

Authors:  W P Frisbie; D Forbes; R A Hummer; S G Pullum
Journal:  Demography       Date:  1998-11

5.  Racial and ethnic differences in determinants of intrauterine growth retardation and other compromised birth outcomes.

Authors:  W P Frisbie; M Biegler; P de Turk; D Forbes; S G Pullum
Journal:  Am J Public Health       Date:  1997-12       Impact factor: 9.308

6.  Maternal health-related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeks.

Authors:  Denise Bijlenga; Kim E Boers; Erwin Birnie; Ben-Willem J Mol; Sylvia C M Vijgen; Joris A M Van der Post; Christianne J De Groot; Robbert J P Rijnders; Paula J Pernet; Frans J Roumen; Rob H Stigter; Friso M C Delemarre; Henk A Bremer; Martina Porath; Sicco A Scherjon; Gouke J Bonsel
Journal:  Qual Life Res       Date:  2011-04-06       Impact factor: 4.147

7.  Intrauterine growth standards: a cross-sectional study in a population of nigerian newborns.

Authors:  Olugbenga A Mokuolu; Omotayo O Adesiyun; Mohammed B Suleiman; Mustapha Bello
Journal:  Pediatr Rep       Date:  2012-09-28

8.  Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT.

Authors:  Kim E Boers; Denise Bijlenga; Ben W J Mol; Saskia LeCessie; Erwin Birnie; Marielle G van Pampus; Rob H Stigter; Kitty W M Bloemenkamp; Claudia A van Meir; Joris A M van der Post; Dick J Bekedam; Lucy S M Ribbert; Addie P Drogtrop; Paulien C M van der Salm; Anjoke J M Huisjes; Christine Willekes; Frans J M E Roumen; Hubertina C J Scheepers; Karin de Boer; Johannes J Duvekot; Jim G Thornton; Sicco A Scherjon
Journal:  BMC Pregnancy Childbirth       Date:  2007-07-10       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.